Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prediagnostic Blood Metal Levels and the Risk of Parkinson's Disease: A Large European Prospective Cohort.
Zhao Y, Ray A, Broberg K, Kippler M, Lill CM, Vineis P, Katzke VA, Rodriguez-Barranco M, Chirlaque MD, Guevara M, Gómez JH, Hansen J, Panico S, Middleton LT, Masala G, Pala V, Vinagre-Aragon A, Zibetti M, Vermeulen R, Peters S. Zhao Y, et al. Among authors: zibetti m. Mov Disord. 2023 Dec;38(12):2302-2307. doi: 10.1002/mds.29602. Epub 2023 Sep 7. Mov Disord. 2023. PMID: 37675653 Free PMC article.
Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.
Ceravolo R, Cossu G, Bandettini di Poggio M, Santoro L, Barone P, Zibetti M, Frosini D, Nicoletti V, Manganelli F, Iodice R, Picillo M, Merola A, Lopiano L, Paribello A, Manca D, Melis M, Marchese R, Borelli P, Mereu A, Contu P, Abbruzzese G, Bonuccelli U. Ceravolo R, et al. Among authors: zibetti m. Mov Disord. 2013 Sep;28(10):1391-7. doi: 10.1002/mds.25585. Epub 2013 Jul 8. Mov Disord. 2013. PMID: 23836370 Free article.
Prevalence and burden of dysautonomia in advanced Parkinson's disease.
Merola A, Romagnolo A, Comi C, Rosso M, Artusi CA, Zibetti M, Lanotte M, Duker AP, Maule S, Lopiano L, Espay AJ. Merola A, et al. Among authors: zibetti m. Mov Disord. 2017 May;32(5):796-797. doi: 10.1002/mds.26970. Epub 2017 Mar 3. Mov Disord. 2017. PMID: 28256092 No abstract available.
Peripheral neuropathy as marker of severe Parkinson's disease phenotype.
Merola A, Rosso M, Romagnolo A, Comi C, Fasano A, Zibetti M, Lopez-Castellanos JR, Cocito D, Lopiano L, Espay AJ. Merola A, et al. Among authors: zibetti m. Mov Disord. 2017 Aug;32(8):1256-1258. doi: 10.1002/mds.27025. Epub 2017 May 8. Mov Disord. 2017. PMID: 28582598 No abstract available.
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson's Disease?
Fabbri M, Zibetti M, Rizzone MG, Giannini G, Borellini L, Stefani A, Bove F, Bruno A, Calandra-Buonaura G, Modugno N, Piano C, Peppe A, Ardolino G, Romagnolo A, Artusi CA, Berchialla P, Montanaro E, Cortelli P, Luigi R, Eleopra R, Minafra B, Pacchetti C, Tufo T, Cogiamanian F, Lopiano L. Fabbri M, et al. Among authors: zibetti m. Mov Disord. 2020 Aug;35(8):1379-1387. doi: 10.1002/mds.28091. Epub 2020 May 25. Mov Disord. 2020. PMID: 32449542 Clinical Trial.
Lipopolysaccharide-binding protein and future Parkinson's disease risk: a European prospective cohort.
Zhao Y, Walker DI, Lill CM, Bloem BR, Darweesh SKL, Pinto-Pacheco B, McNeil B, Miller GW, Heath AK, Frissen M, Petrova D, Sánchez MJ, Chirlaque MD, Guevara M, Zibetti M, Panico S, Middleton L, Katzke V, Kaaks R, Riboli E, Masala G, Sieri S, Zamora-Ros R, Amiano P, Jenab M, Peters S, Vermeulen R. Zhao Y, et al. Among authors: zibetti m. J Neuroinflammation. 2023 Jul 21;20(1):170. doi: 10.1186/s12974-023-02846-2. J Neuroinflammation. 2023. PMID: 37480114 Free PMC article.
231 results